A Randomized Phase-II Pilot Trial of Docetaxel and Prednisone Versus Radiation Therapy Plus Docetaxel and Prednisone in Patients With Nonmetastatic and Oligometastatic Castrate Resistant Prostate Cancer.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 06 Mar 2017
At a glance
- Drugs Docetaxel; Prednisone
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 18 Oct 2011 Actual initiation date (Mar 2011) added as reported by ClinicalTrials.gov.
- 18 Oct 2011 Planned End Date changed from 1 Mar 2015 to 1 Jul 2011 as reported by ClinicalTrials.gov.